D.E. Shaw & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-60,000
Closed -$3.57M 4566
2025
Q4
$3.57M Hold
60,000
﹤0.01% 2595
2025
Q3
$3.25M Hold
60,000
﹤0.01% 2574
2025
Q2
$3.3M Hold
60,000
﹤0.01% 2354
2025
Q1
$4.24M Hold
60,000
﹤0.01% 2015
2024
Q4
$3.94M Buy
60,000
+26,200
+78% +$1.75M ﹤0.01% 2171
2024
Q3
$2.38M Buy
+33,800
New +$2.83M ﹤0.01% 2589
2022
Q1
Sell
-19,000
Closed -$1.68M 5546
2021
Q4
$1.68M Sell
19,000
-17,100
-47% -$1.41M ﹤0.01% 3513
2021
Q3
$2.79M Buy
36,100
+17,100
+90% +$1.35M ﹤0.01% 2697
2021
Q2
$1.58M Sell
19,000
-30,000
-61% -$2.38M ﹤0.01% 3162
2021
Q1
$3.7M Buy
49,000
+9,000
+23% +$735K ﹤0.01% 2083
2020
Q4
$3.51M Hold
40,000
﹤0.01% 2141
2020
Q3
$3.04M Buy
40,000
+29,400
+277% +$2.97M ﹤0.01% 2059
2020
Q2
$1.31M Sell
10,600
-29,400
-74% -$2.92M ﹤0.01% 2739
2020
Q1
$3.38M Buy
40,000
+30,000
+300% +$2.58M 0.01% 1760
2019
Q4
$846K Hold
10,000
﹤0.01% 3090
2019
Q3
$674K Hold
10,000
﹤0.01% 3063
2019
Q2
$857K Buy
+10,000
New +$855K ﹤0.01% 2771
2018
Q1
Sell
-20,000
Closed -$1.78M 3494
2017
Q4
$1.78M Hold
20,000
﹤0.01% 2219
2017
Q3
$1.86M Hold
20,000
﹤0.01% 2087
2017
Q2
$1.82M Hold
20,000
﹤0.01% 2031
2017
Q1
$1.76M Sell
20,000
-20,100
-50% -$1.79M ﹤0.01% 1923
2016
Q4
$3.32M Buy
40,100
+10,000
+33% +$860K 0.01% 1607
2016
Q3
$2.79M Hold
30,100
﹤0.01% 1674
2016
Q2
$2.34M Buy
30,100
+3,400
+13% +$289K ﹤0.01% 1815
2016
Q1
$2.2M Sell
26,700
-39,500
-60% -$3.21M ﹤0.01% 1816
2015
Q4
$6.93M Buy
66,200
+10,000
+18% +$1.04M 0.01% 1189
2015
Q3
$5.92M Buy
56,200
+26,200
+87% +$3.5M 0.01% 1273
2015
Q2
$4.1M Buy
+30,000
New +$3.72M 0.01% 1617
2015
Q1
Sell
-37,500
Closed -$3.39M 3640
2014
Q4
$3.39M Hold
37,500
﹤0.01% 1861
2014
Q3
$2.71M Hold
37,500
﹤0.01% 1998
2014
Q2
$2.33M Hold
37,500
﹤0.01% 2190
2014
Q1
$2.56M Buy
37,500
+4,700
+14% +$346K ﹤0.01% 2145
2013
Q4
$2.31M Hold
32,800
﹤0.01% 2391
2013
Q3
$2.37M Buy
+32,800
New +$2.18M ﹤0.01% 2272

Other funds holding BMRN